2-Chloropyridine

2-Chloropyridine

SCHEMBL1647769

Clc1ccccn1.NCCOc1ccccn1

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.55
NPC1 O15118 2/20 0.44
ALDH1A1 P00352 2/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C19 P33261 1/20 0.44
KDM4E B2RXH2 3/20 0.41
TAAR1 Q96RJ0 1/20 0.41
HRH1 P35367 2/20 0.39
LTA4H P09960 2/20 0.37
PLA2G2A P14555 1/20 0.37
HTR1B P28222 1/20 0.35
LMNA P02545 2/20 0.34
CYP1A2 P05177 1/20 0.34
POLB P06746 1/20 0.34
CCR1 P32246 1/20 0.34
CCR5 P51681 1/20 0.34
CCR8 P51685 1/20 0.34
METAP1 P53582 1/20 0.34
BLM P54132 1/20 0.34
HIF1A Q16665 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1178754 0.89 KDM4E (0.50) NPC1ALDH1A1CYP2D6CYP2C19KDM4E
Hydrochloric Acid SCHEMBL31656522 0.87 KDM4E (0.54) NPC1ALDH1A1CYP2D6CYP2C19KDM4E
Hydrochloric Acid SCHEMBL1954121 0.87 KDM4E (0.54) NPC1ALDH1A1CYP2D6CYP2C19KDM4E
Hydrochloric Acid SCHEMBL4838526 0.87 KDM4E (0.54) NPC1ALDH1A1CYP2D6CYP2C19KDM4E
2-Chloropyridine SCHEMBL28052103 0.85 TDP1 (0.76) TDP1NPC1KDM4ETAAR1HRH1
SCHEMBL2002016 0.80 HRH1 (0.53) NPC1ALDH1A1CYP2D6CYP2C19KDM4E
SCHEMBL4190714 0.77 KDM4E (0.50) TDP1NPC1ALDH1A1CYP2D6CYP2C19
SCHEMBL29263736 0.77 HRH1 (0.55) NPC1ALDH1A1CYP2D6CYP2C19HRH1
SCHEMBL13822632 0.77 HTR1B (0.42) KDM4ETAAR1LTA4HPLA2G2AHTR1B
2-Chloropyridine SCHEMBL27904570 0.76 TDP1 (0.67) TDP1NPC1KDM4EHRH1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2303329-A1 ANTIFUNGAL COMBINATION THERAPY F2G Limited (GB) 2011-04-06 EP disclosed
WO-2009144473-A1 ANTIFUNGAL COMBINATION THERAPY F2G LIMITED (GB) 2009-12-03 WO disclosed
EP-2097413-A1 2-[(2-SUBSTITUTED)-IND0LIZIN-3-YL]-2-OXO-ACETAMIDE DERIVATIVES AS ANTIFUNGAL AGENTS F2G Limited (GB) 2009-09-09 EP disclosed
WO-2008062182-A1 2- [ (2-SUBSTITUTED) -IND0LIZIN-3-YL] -2-OXO-ACETAMIDE DERIVATIVES AS ANTIFUNGAL AGENTS F2G LTD (GB) 2008-05-29 WO disclosed